Cbl-ArgBP2 complex mediates ubiquitination and degradation of c-Abl

Biochemical Journal

Volumn 370, Issue 1, 2003, Pages 29-34

  Soubeyran, Philippe ^a   Barac, Ana ^a   Szymkiewicz, Iwona ^a   Dikic, Ivan ^a  

^a LUDWIG INSTITUTE FOR CANCER RESEARCH   (Sweden)

Author keywords

Abl; ArgBP2; Cbl; Degradation; Tyrosine kinase; Ubiquitination

Indexed keywords

DEGRADATION; DRUG INTERACTIONS; PROTEINS; STABILIZATION;

COMPLEXES;

BIOCHEMISTRY;

ARGININE BINDING PROTEIN 2; BINDING PROTEIN; CBL PROTEIN; LIGASE; PROTEIN; PROTEIN TYROSINE KINASE; UBIQUITIN; UNCLASSIFIED DRUG;

ARTICLE; GENETIC TRANSFECTION; HUMAN; HUMAN CELL; IMMUNOBLOTTING; IMMUNOPRECIPITATION; MOLECULAR INTERACTION; PHOSPHORYLATION; PRIORITY JOURNAL; PROTEIN DEGRADATION;

ANIMALS; CHO CELLS; CRICETINAE; HOMEODOMAIN PROTEINS; HUMANS; HYDROLYSIS; ONCOGENE PROTEIN V-CBL; PHOSPHORYLATION; PROTEIN BINDING; PROTO-ONCOGENE PROTEINS C-ABL; RETROVIRIDAE PROTEINS, ONCOGENIC; TWO-HYBRID SYSTEM TECHNIQUES; UBIQUITIN;

EID: 0037442804     PISSN: 02646021     EISSN: None     Source Type: Journal    
DOI: 10.1042/BJ20021539     Document Type: Article

References (21)

1. Van Etten, R. A. (1999) Cycling, stressed-out and nervous: cellular functions of c-Abl. Trends. Cell. Biol. 9, 179-186
2. Kruh, G. D., Perego, R., Miki, T. and Aaronson, S. A. (1990) The complete coding sequence of arg defines the Abelson subfamily of cytoplasmic tyrosine kinases. Proc. Natl. Acad. Sci. U.S.A. 87, 5802-5806
3. Pluk, H., Dorey, K. and Superti-Furga, G. (2002) Autoinhibition of c-Abl. Cell (Cambridge, Mass.) 108, 247-259
4. Gotoh, A. and Broxmeyer, H. E. (1997) The function of BCR/ABL and related proto-oncogenes. Curr. Opin. Hematol. 4, 3-11
5. Echarri, A. and Pendergast, A. M. (2001) Activated c-Abl is degraded by the ubiquitin-dependent proteasome pathway. Curr. Biol. 11, 1759-1765
6. Thien, C. B. and Langdon, W. Y. (2001) Cbl: many adaptations to regulate protein tyrosine kinases. Nat. Rev. Mol. Cell. Biol. 2, 294-307
7. Shishido, T., Akagi, T., Ouchi, T., Georgescu, M. M., Langdon, W. Y. and Hanafusa, H. (2000) The kinase-deficient Src acts as a suppressor of the Abl kinase for Cbl phosphorylation. Proc. Natl. Acad. Sci. U.S.A. 97, 6439-6444
8. Bonifacino, J. S. and Weissman, A. M. (1998) Ubiquitin and the control of protein fate in the secretory and endocytic pathways. Annu. Rev. Cell. Dev. Biol. 14, 19-57
9. Soubeyran, P., Kowanetz, K., Szymkiewicz, I., Langdon, W. Y. and Dikic, I. (2002) Cbl-CIN85-endophilin complex mediates ligand-induced downregulation of EGF receptors. Nature (London) 416, 183-187
10. Petrelli, A., Gilestro, G. F., Lanzardo, S., Comoglio, P. M., Migone, N. and Giordano, S. (2002) The endophilin-CIN85-Cbl complex mediates ligand-dependent downregulation of c-Met. Nature (London) 416, 187-190
11. Dikic, I. (2002) CIN85/CMS family of adaptor molecules. FEBS Lett. 529, 110-115
12. Wang, B., Golemis, E. A. and Kruh, G. D. (1997) ArgBP2, a multiple Src homology 3 domain-containing, Arg/Abl-interacting protein, is phosphorylated in v-Abl-transformed cells and localized in stress fibers and cardiocyte Z-disks. J. Biol. Chem. 272, 17542-17550
13. Kimura, A., Baumann, C. A., Chiang, S. H. and Saltiel, A. R. (2001) The sorbin homology domain: a motif for the targeting of proteins to lipid rafts. Proc. Natl. Acad. Sci. U.S.A. 98, 9098-9103
14. Ben-Neriah, Y., Daley, G. O., Mes-Masson, A. M., Witte, O. N. and Baltimore, D. (1986) The chronic myelogenous leukemia-specific P210 protein is the product of the bcr/abl hybrid gene. Science (Washington, D.C.) 233, 212-214
15. Andoniou, C. E., Thien, C. B. and Langdon, W. Y. (1994) Tumour induction by activated abl involves tyrosine phosphorylation of the product of the cbl oncogene. EMBO J. 13, 4515-4523
16. Miyoshi-Akiyama, T., Aleman, L. M., Smith, J. M., Adler, C. E. and Mayer, B. J. (2001) Regulation of Cbl phosphorylation by the Abl tyrosine kinase and the Nck SH2/SH3 adaptor. Oncogene 20, 4058-4069
17. Andoniou, C. E., Lill, N. L., Thien, C. B., Lupher, Jr, M. L., Ota, S., Bowtell, D. D., Scaife, R. M., Langdon, W. Y. and Band, H. (2000) The Cbl proto-oncogene product negatively regulates the Src-family tyrosine kinase Fyn by enhancing its degradation. Mol. Cell. Biol. 20, 851-867
18. Rao, N., Ghosh, A. K., Ota, S., Zhou, P., Reddi, A. L., Hakezi, K., Druker, B. K., Wu, J. and Band, H. (2001) The non-receptor tyrosine kinase Syk is a target of Cbl-mediated ubiquitylation upon B-cell receptor stimulation. EMBO J. 20, 7085-7095
19. Rao, N., Miyake, S., Reddi, A. L., Douillard, P., Ghosh, A. K., Dodge, I. L., Zhou, P., Fernandes, N. D. and Band, H. (2002) Negative regulation of Lck by Cbl ubiquitin ligase. Proc. Natl. Acad. Sci. U.S.A. 99, 3794-3799
20. Dai, Z., Quackenbush, R. C., Courtney, K. D., Grove, M., Cortez, D., Reuther, G. W. and Pendergast, A. M. (1998) Oncogenic Abl and Src tyrosine kinases elicit the ubiquitin-dependent degradation of target proteins through a Ras-independent pathway. Genes Dev. 12, 1415-1424
21. Westphal, R. S., Soderling, S. H., Alto, N. M., Langeberg, L. K. and Scott, J. D. (2000) Scar/WAVE-1, a Wiskott-Aldrich syndrome protein, assembles an actin-associated multi-kinase scaffold. EMBO J. 19, 4589-4600